Literature DB >> 26642341

Post-transplantation-emerging anti-HLA DQA1/DQB1 antibody possibly responsible for graft rejection after myeloablative-unrelated marrow grafting.

H Yabe1, T Morimoto2, H Takakura2, M Okuya3, R Ikegaya2, S Kato1, T Sugimoto4, F Tsuchida4, M Murakami4, H Mochizuki2, M Yabe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26642341     DOI： 10.1038/bmt.2015.292

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Therapeutic preparations of IVIg contain naturally occurring anti-HLA-E antibodies that react with HLA-Ia (HLA-A/-B/-Cw) alleles.

Authors:  Mepur H Ravindranath; Paul I Terasaki; Tho Pham; Vadim Jucaud; Satoru Kawakita
Journal:  Blood       Date:  2013-01-10       Impact factor: 22.113

2.  Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

Authors:  Corey Cutler; Haesook T Kim; Lixian Sun; Doreen Sese; Brett Glotzbecker; Philippe Armand; John Koreth; Vincent Ho; Edwin Alyea; Karen Ballen; Jerome Ritz; Robert J Soiffer; Edgar Milford; Joseph H Antin
Journal:  Blood       Date:  2011-09-22       Impact factor: 22.113

3.  Anti-HLA antibodies in double umbilical cord blood transplantation.

Authors:  Claudio G Brunstein; Harriet Noreen; Todd E DeFor; David Maurer; Jeffrey S Miller; John E Wagner
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-03       Impact factor: 5.742

4.  Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.

Authors:  Stefan O Ciurea; Peter F Thall; Xuemei Wang; Sa A Wang; Ying Hu; Pedro Cano; Fleur Aung; Gabriela Rondon; Jeffrey J Molldrem; Martin Korbling; Elizabeth J Shpall; Marcos de Lima; Richard E Champlin; Marcelo Fernandez-Vina
Journal:  Blood       Date:  2011-10-03       Impact factor: 22.113

5.  Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT.

Authors:  S Yoshihara; E Maruya; K Taniguchi; K Kaida; R Kato; T Inoue; T Fujioka; H Tamaki; K Ikegame; M Okada; T Soma; K Hayashi; N Fujii; T Onuma; Y Kusunoki; H Saji; H Ogawa
Journal:  Bone Marrow Transplant       Date:  2011-06-20       Impact factor: 5.483

6.  "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males.

Authors:  Luis E Morales-Buenrostro; Paul I Terasaki; Lluvia A Marino-Vázquez; Jar-How Lee; Nadim El-Awar; Josefina Alberú
Journal:  Transplantation       Date:  2008-10-27       Impact factor: 4.939

7.  The pattern of HLA-DR and HLA-DQ antigen expression on clonable subpopulations of human myeloid progenitor cells.

Authors:  R L Sparrow; N Williams
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

8.  Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.

Authors:  Hisashi Yamamoto; Naoyuki Uchida; Naofumi Matsuno; Hikari Ota; Kosei Kageyama; Sachie Wada; Daisuke Kaji; Aya Nishida; Kazuya Ishiwata; Shinsuke Takagi; Masanori Tsuji; Yuki Asano-Mori; Go Yamamoto; Koji Izutsu; Kazuhiro Masuoka; Atsushi Wake; Akiko Yoneyama; Shigeyoshi Makino; Shuichi Taniguchi
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-24       Impact factor: 5.742

9.  Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.

Authors:  F Ginevri; A Nocera; P Comoli; A Innocente; M Cioni; A Parodi; I Fontana; A Magnasco; A Nocco; A Tagliamacco; A Sementa; P Ceriolo; L Ghio; M Zecca; M Cardillo; G Garibotto; G M Ghiggeri; F Poli
Journal:  Am J Transplant       Date:  2012-09-07       Impact factor: 8.086

10.  The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors.

Authors:  Anna Koclega; Miroslaw Markiewicz; Urszula Siekiera; Alicja Dobrowolska; Mizia Sylwia; Monika Dzierzak-Mietla; Patrycja Zielinska; Malgorzata Sobczyk Kruszelnicka; Andrzej Lange; Slawomira Kyrcz-Krzemien
Journal:  Bone Marrow Res       Date:  2012-10-24
View more
  2 in total

Review 1.  Allogeneic hematopoietic stem cell transplantation for inherited metabolic disorders.

Authors:  Hiromasa Yabe
Journal:  Int J Hematol       Date:  2022-05-20       Impact factor: 2.490

Review 2.  Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sarah Morin-Zorman; Pascale Loiseau; Jean-Luc Taupin; Sophie Caillat-Zucman
Journal:  Front Immunol       Date:  2016-08-12       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.